Skip to main content

CYTOKINETICS INC

For the period ended Dec 31, 2025. Filed Feb 26, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 26, 2026

CYTK$56.18+1.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 8. Consolidated Statements of Cash Flows

CONSOLIDATED STATEM ENTS OF CASH FLOWS

(In thousands)

Years Ended December 31,
202520242023
Cash flows from operating activities:
Net loss$(784,955)$(589,526)$(526,244)
Adjustments to reconcile net loss to net cash used in operating activities:
Non-cash interest expense on liabilities related to revenue participation right purchase agreement58,36748,91729,474
Stock-based compensation expense112,28697,84072,065
Non-cash lease expense5,6484,3143,750
Loss on disposition of property and equipment—45—
Depreciation of property and equipment10,1259,53111,892
Change in fair value of derivative liabilities(4,200)(1,300)—
Change in fair value of liabilities related to RPI Transactions20019,600—
Realized (loss) gain on investment, net(25)(19)35
Interest receivable and amortization on investments(15,977)(32,515)(15,735)
Non-cash interest expense related to debt22,90111,5597,341
Debt conversion expense121,249——
Changes in operating assets and liabilities:
Accounts receivable(1,114)(15,367)(1,136)
Prepaid and other assets(2,933)(2,438)1,596
Accounts payable2,663(4,483)(3,483)
Deferred revenue(50,758)52,370—
Accrued and other liabilities33,60314,18217,103
Operating lease liabilities(10,839)(7,244)(1,406)
Other non-current liabilities(6,250)(1,356)(9,585)
Net cash used in operating activities(510,009)(395,890)(414,333)
Cash flows from investing activities:
Purchases of investments(1,063,173)(1,293,416)(635,211)
Investment in non-marketable equity security(5,000)——
Maturities of investments1,103,645744,225870,905
Sales of investments6,001—4,975
Purchases of property and equipment(24,807)(3,906)(1,416)
Net cash (used in) provided by investing activities16,666(553,097)239,253
Cash flows from financing activities:
Repayment of finance lease liabilities(204)(939)(858)
Repayment of term loans(10,809)(8,679)—
Repayment of convertible debt(402,500)——
Proceeds from issuance of convertible debt, net729,460——
Proceeds from draw on RPI Multi Tranche Loan175,000200,00050,000
Proceeds from issuance of common stock related to at-the-market offering, net of issuance costs—93,640164,233
Proceeds from issuance of common stock related to public offering, net of issuance costs—563,204—
Proceeds from issuance of common stock related to private placement, net of issuance costs—50,000—
Proceeds from issuance of common stock under equity incentive and stock purchase plans35,97953,01618,459
Taxes paid related to net share settlement of equity awards(2,468)(19,631)(10,517)
Net cash provided by financing activities524,458930,611221,317
Effect of exchange rate changes(715)209(20)
Net (decrease) increase in cash, cash equivalents, and restricted cash30,400(18,167)46,217
Cash, cash equivalents, and restricted cash, beginning of period95,232113,39967,182
Cash, cash equivalents, and restricted cash, end of period$125,632$95,232$113,399
Supplemental cash flow disclosures:
Cash paid for interest$22,914$25,970$10,295
Non-cash investing and financing activities:
Right-of-use assets recognized in exchange for operating lease obligations$6,255$481$—
Amounts unpaid for purchases of property and equipment$2,650$3,345$—
Issuance of common stock in connection with repurchase of convertible note$107,920$—$—
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.